HOME >> BIOLOGY >> NEWS
Treatable psychiatric symptoms common with degenerative brain disease

Potentially treatable psychiatric problems are common in patients with degenerative brain diseases affecting movement and coordination, according to a study by Johns Hopkins scientists. Up to 80 per cent of those with either Huntington's disease or degenerative diseases affecting the cerebellum also suffer from depression, impaired thinking and changes in personality, the study found.

"Traditionally, there has been this distinction between neurological and psychiatric disorders, but it is an artificial distinction," said lead author Russell L. Margolis, M.D., associate professor of psychiatry at Hopkins and director of the Laboratory of Genetic Neurobiology.

"Indeed, the high rate of psychiatric disorders in these patients suggests that many, if not most, can benefit from treatment, even if the course of the brain disease itself cannot be reversed. Many symptoms can be eased, and the quality of life for these patients and their families can be greatly enhanced," says Margolis.

"Our findings of high rates of psychiatric disorders in Huntington's disease confirm the results of previous studies, and we believe we've found the first well-established link between serious psychiatric disorders and the cerebellum, a region at the back of the brain densely packed with nerve cells," notes Margolis.

In the study, Margolis and his colleagues conducted detailed interviews and analyzed brain images of three groups: 31 patients with degenerative cerebellar disease, 21 patients with Huntington's disease and 29 people who had no signs of brain disease. The results, reported in the August issue of the American Journal of Psychiatry, found that 77 per cent of patients with cerebellar disease had psychiatric disorders, and 81 per cent of Huntington's disease patients did so, rates nearly double those seen in healthy control subjects (41 per cent). Sixty-eight per cent of those with cerebellar disease suffered from mood disorders like depression, com
'"/>

Contact: Trent Stockton
tstockt1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
6-Aug-2002


Page: 1 2 3

Related biology news :

1. Brain serotonin enzyme finding might explain psychiatric disorders
2. Researchers caution against linking strep, neuropsychiatric disorders
3. New tool for studying animal models of neurological and psychiatric diseases
4. Environmental and genetic factors influence development of psychiatric disorder
5. Chronic respiratory symptoms prevalent among Alaska natives
6. Ritalin may improve Parkinsons symptoms, OHSU study says
7. UT Southwestern research halts narcolepsy symptoms
8. Dec. 17 JAMA study shows new biologic drug reduces psoriasis symptoms, improves quality of life
9. Imperial researchers show novel flu treatment eliminates symptoms in mice
10. Gene therapy delays death in mouse with symptoms of Lou Gehrigs disease
11. Spectrum of West Nile symptoms includes paralysis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the company has ... Sciences Awards as "Most Outstanding in eClinical Solutions" ... of recognition and growth for MedNet, which has effectively ... iMedNet ™ , MedNet,s flagship eClinical ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... , Nov. 30, 2016  GenomOncology today announced the ... President of Medical Affairs.  Dr. Coleman will ... the company,s proprietary knowledge-enabled platform. The GenomOncology software suite empowers ... genetic sequencing data and clinical decision support, from quality control ... , ...
(Date:11/30/2016)... - Portage Biotech Inc. ("Portage" or "the Company") (OTC: ... announce the formation of EyGen, Ltd. a new ... through proof of concept. EyGen,s lead asset is ... Limited and being developed for topical ophthalmic delivery ... diseases. This agent has the potential to become ...
(Date:11/30/2016)... 2016  The Allen Institute for Cell Science ... publicly available collection of gene edited, fluorescently tagged ... cellular structures with unprecedented clarity. Distributed through the ... are a crucial first step toward visualizing the ... makes human cells healthy and what goes wrong ...
(Date:11/30/2016)... Nov. 30, 2016  Tempus, a technology company ... and Penn,s Abramson Cancer Center have partnered to ... response to immunotherapy treatment based on next generation ... part of a research collaboration, Tempus will provide ... cancer patient data to Penn. Utilizing next-generation sequencing, ...
Breaking Biology Technology:
Cached News: